Oliman, Dalma .

HRN: 23-52-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
CEFUROXIME 1.5GM (VIAL)
08/15/2023
08/16/2023
IV
1.5g
Loading
For Stat Exploration
Checking Final Appropriateness 
08/15/2023
CEFUROXIME 1.5GM (VIAL)
08/15/2023
08/16/2023
IV
1.5g
Q8
S/p Stat Vulvar Exploration
Checking Final Appropriateness 
09/26/2023
CEFUROXIME 500MG (TAB)
09/26/2023
10/03/2023
ORAL
500mg
BID
RMLE, With Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: